About Crescent Formulations Private Limited
Data last updated:
Crescent Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 28 October 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC070991. Its GSTIN is 36AAECC2377B1ZZ (Telangana). The company holds 5 GST registrations, all of them active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.3 Cr. It is led by directors including Javeed Shaik and Shaik Junaid.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 4 – 7 – 11/4/C Crescent Towers Raghavendra Nagar Nacharam, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2024, the company reported a revenue of ₹33.11 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.54 Cr (net margin 4.7%) and EBITDA of ₹3.8 Cr (EBITDA margin 11.5%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.
The company has about 171 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Crescent Formulations. As per MCA filings, the company has open charges of ₹9.9 Cr and satisfied charges of ₹12 Cr on record. Court records list 3 cases involving the company, including 2 filed against it; 1 case is pending. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹2.29 Cr; the latest was in September 2018.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cfpl.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address4 – 7 – 11/4/C Crescent Towers Raghavendra Nagar Nacharam, Hyderabad, Telangana, India – 500076
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Crescent Formulations Private Limited
The main business activity of Crescent Formulations is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Crescent Formulations Private Limited FY 2024 filings available
Crescent Formulations Private Limited reported revenue of ₹33.11 Cr (up 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Crescent Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 10% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Crescent Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.8 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.54 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Crescent Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Crescent Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Crescent Formulations Private Limited
Crescent Formulations Private Limited is audited by N.S.R.A.PRASAD & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| N.S.R.A.PRASAD & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Crescent Formulations Private Limited
Crescent Formulations has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Javeed Shaik | Director | 24 Feb 2017 | 9 Years 7 Months | Current |
| Shaik Junaid | Director | 04 May 2023 | 3 Years 5 Months | Current |
| Shaik Janimiya | Director | 28 Oct 2010 | 15 Years 11 Months | Current |
| Shaik Thahera | Director | 28 Oct 2010 | 15 Years 11 Months | Current |
Ownership and Shareholding of Crescent Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Crescent Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2023 | Hdfc Bank Limited | ₹40 Lakh | Open |
| 08 Feb 2023 | Others | ₹4 Cr | Open |
| 07 Jun 2011 | Others | ₹5.5 Cr | Open |
| 08 Feb 2023 | Hdfc Bank Limited | ₹10.09 Cr | Satisfied |
| 23 Sep 2020 | Others | ₹96 Lakh | Satisfied |
Total charge records: 7 View all charges
Deals & Funding of Crescent Formulations Private Limited
Crescent Formulations Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹2.29 Cr; the latest was in September 2018.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2018 | Secondary share transfer | Buyer: an individual Seller: an individual | |
| Jun 2015 | Funding round | ₹30 Lakh | Investors: an individual |
| Mar 2012 | Funding round | ₹1.99 Cr | Investors: 4 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Crescent Formulations Private Limited
Crescent Formulations Private Limited has 3 court cases on record: 2 filed against it, 1 where it is another party. 1 case is pending and 2 are disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Execution petition | Filed against the company by an individual | Pending |
| District court, Rangareddy, Telangana | Civil suit | Filed against the company by an individual | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Company is another party | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Crescent Formulations Private Limited
Crescent Formulations operates one associated brand: Crescent Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies pharmaceuticals for health needs in psychiatry, neurology, and pain management. | cfpl.co.in |
Competitors & Alternatives of Crescent Formulations Private Limited
Brands and companies operating in the same space as Crescent Formulations Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Jubilant Life Sciences | Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India | 1978 |
 Akums | CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India | 2004 |
 Nectar Lifesciences | Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India | 1995 |
 Windlas | Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India | 2001 |
 Unither | Contract development and manufacturing organization for proprietary and generic drugs | Paris, France | 1993 |
 Recipharm | Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden | 1995 |
 CoreRx | CDMO with a focus on early phase drug product development | Clearwater, United States | 2006 |
 Aenova Group | CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | Starnberg, Germany | 2008 |
 Zambon Pharma | APIs and finished drugs are developed and manufactured in pharmaceuticals. | Bresso, Italy | 1906 |
 Leukocare | Proprietary stabilizing solutions for biologics formulations are developed. | Munich, Germany | 2003 |
Employees and EPFO Compliance at Crescent Formulations Private Limited
Crescent Formulations Private Limited has a workforce of 171 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Crescent Formulations Private Limited
Crescent Formulations has one previous CIN (Corporate Identification Number): U24232AP2010PTC070991. The current CIN is U24232TG2010PTC070991, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2010PTC070991 | Current |
| U24232AP2010PTC070991 | Previous |
Recent Activity on Crescent Formulations Private Limited
Credit Ratings, Litigation & Regulatory Alerts for Crescent Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Crescent Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Crescent Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Crescent Formulations Private Limited
Crescent Formulations has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECC2377B1ZZ | Telangana | Active | 01 Jul 2017 |
| 02AAECC2377B1ZA | Himachal Pradesh | Active | 01 Jul 2017 |
| 37AAECC2377B1ZX | Andhra Pradesh | Active | 01 Jul 2017 |
| 05AAECC2377B1Z4 | Uttarakhand | Active | 02 Jan 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Crescent Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Crescent Formulations Private Limited
Crescent Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in wholesale, within the trading industry. It was incorporated on 28 October 2010 (16+ years old) and is registered under CIN U24232TG2010PTC070991.
Crescent Formulations reported revenue of ₹33.11 Cr for FY 2024 (up 10% YoY).
Crescent Formulations has 4 current directors:
- Javeed Shaik - Director
- Shaik Junaid - Director
- Shaik Janimiya - Director
- Shaik Thahera - Director
Crescent Formulations reported a net profit of ₹1.54 Cr (net margin 4.7%) and EBITDA of ₹3.8 Cr (EBITDA margin 11.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Crescent Formulations is 4% over three years and 3% over five years. In the latest year (FY 2024) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Crescent Formulations is 36AAECC2377B1ZZ, registered in Telangana. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 02AAECC2377B1ZA (Himachal Pradesh), 37AAECC2377B1ZX (Andhra Pradesh), 05AAECC2377B1Z4 (Uttarakhand).
The CIN (Corporate Identification Number) of Crescent Formulations is U24232TG2010PTC070991. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crescent Formulations has 3 court cases on record: 2 filed against it. 1 is pending.
Crescent Formulations was incorporated on 28 October 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.